DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Stone GW, McCullough PA, Tumlin JA. et al.
Fenoldopam mesylate for the prevention of contrast-induced
nephropathy: a randomized controlled trial.
JAMA 2003; 290: 2284-2291
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.